Dr Allan Stensballe [Translational Biomarkers for Pain and Precision Medicine research Omics research group at Aalborg University]

Host: Prof Jonathan Blackburn [Head of Div Chemical and Systems Biology/Deputy Director of the IDM]

Dr Allan Stensballe has a strong background in protein chemistry and applied proteomics for the study of human disease pathology. He heads the Translational Biomarkers for Pain and Precision Medicine research Omics research group at Aalborg University (www.aau.dk) in Denmark.  Aalborg University ranks #1 among European engineering universities. Dr. Stensballes research group aims to unravel the molecular mechanisms of multiple autoimmune-related disorders e.g. arthritis, neuroinflammation and inflammatory bowel diseases by application of proteomics approaches to detect potential biomarkers for patient subtyping as well as predicting treatment outcomes.  In this talk Dr. Stensballe will summarize key precision proteomics technologies to investigate and unravel the molecular disease mechanisms.  A specific focus will be on proteomics approaches to subtype common autoimmune disorders like rheumatoid arthritis, Lupus and multiple sclerosis as well as osteoarthritis. Similar, recent applications of advanced proteomics approaches to study neuroinflammation in stress and translational studies of sepsis related impact on the human brain by application of animal models.